RESPONSE PENDING: Your Meeting with Tanushree Banerjee Tomorrow...
Here is the latest financial fact sheet of AAREY DRUGS. For more details, see the AAREY DRUGS quarterly results and AAREY DRUGS share price.
1 Day | % | -3.8 |
No. of shares | m | 28.05 |
1 Week | % | 12.4 |
1 Month | % | 14.9 |
1 Year | % | 93.1 |
52 week H/L | Rs | 68.0/26.8 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
AAREY DRUGS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 64 | 30 | 42 | 64 | 51 | |
Low | Rs | 26 | 12 | 13 | 22 | 22 | |
Sales per share (Unadj.) | Rs | 151.7 | 128.4 | 149.0 | 194.2 | 165.1 | |
Earnings per share (Unadj.) | Rs | 2.8 | 2.5 | 2.8 | 2.6 | 1.5 | |
Diluted earnings per share | Rs | 2.3 | 2.1 | 2.3 | 2.3 | 1.3 | |
Cash flow per share (Unadj.) | Rs | 3.2 | 2.9 | 3.2 | 3.4 | 2.1 | |
Dividends per share (Unadj.) | Rs | 0.10 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0.2 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 36.0 | 38.5 | 41.3 | 43.9 | 45.3 | |
Adj. book value per share | Rs | 30.0 | 32.1 | 34.4 | 39.7 | 41.0 | |
Shares outstanding (eoy) | m | 23.38 | 23.38 | 23.38 | 25.38 | 25.38 | |
Price / Sales ratio | x | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | |
Avg P/E ratio | x | 16.1 | 8.4 | 9.9 | 16.8 | 24.5 | |
P/CF ratio (eoy) | x | 14.0 | 7.3 | 8.7 | 12.9 | 17.3 | |
Price / Book Value ratio | x | 1.3 | 0.5 | 0.7 | 1.0 | 0.8 | |
Dividend payout | % | 3.6 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 1,053 | 486 | 644 | 1,099 | 925 | |
Total wages/salary | Rs m | 4 | 3 | 2 | 7 | 6 |
AAREY DRUGS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 3,547 | 3,001 | 3,484 | 4,928 | 4,190 | |
Other income | Rs m | 43 | 67 | 70 | 27 | 27 | |
Total revenues | Rs m | 3,590 | 3,068 | 3,554 | 4,954 | 4,217 | |
Gross profit | Rs m | 79 | 32 | 47 | 114 | 77 | |
Depreciation | Rs m | 10 | 9 | 9 | 20 | 16 | |
Interest | Rs m | 22 | 18 | 24 | 20 | 29 | |
Profit before tax | Rs m | 90 | 72 | 83 | 100 | 60 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 24 | 14 | 18 | 35 | 22 | |
Profit after tax | Rs m | 65 | 58 | 65 | 66 | 38 | |
Gross profit margin | % | 2.2 | 1.1 | 1.3 | 2.3 | 1.8 | |
Effective tax rate | % | 27.2 | 20.0 | 21.5 | 34.7 | 37.2 | |
Net profit margin | % | 1.8 | 1.9 | 1.9 | 1.3 | 0.9 |
AAREY DRUGS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,330 | 1,813 | 2,184 | 2,188 | 2,706 | |
Current liabilities | Rs m | 576 | 1,003 | 1,308 | 1,267 | 1,681 | |
Net working cap to sales | % | 21.2 | 27.0 | 25.1 | 18.7 | 24.5 | |
Current ratio | x | 2.3 | 1.8 | 1.7 | 1.7 | 1.6 | |
Inventory Days | Days | 0 | 1 | 0 | 9 | 6 | |
Debtors Days | Days | 108,824,991 | 116,927,466 | 169,723,827 | 1,009 | 1,653 | |
Net fixed assets | Rs m | 127 | 127 | 147 | 264 | 207 | |
Share capital | Rs m | 234 | 234 | 234 | 254 | 254 | |
"Free" reserves | Rs m | 609 | 666 | 732 | 859 | 897 | |
Net worth | Rs m | 842 | 900 | 965 | 1,113 | 1,151 | |
Long term debt | Rs m | 0 | 0 | 0 | 33 | 44 | |
Total assets | Rs m | 1,457 | 1,941 | 2,330 | 2,452 | 2,913 | |
Interest coverage | x | 5.0 | 5.1 | 4.4 | 5.9 | 3.1 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 2.4 | 1.5 | 1.5 | 2.0 | 1.4 | |
Return on assets | % | 6.0 | 3.9 | 3.8 | 3.5 | 2.3 | |
Return on equity | % | 7.8 | 6.4 | 6.7 | 5.9 | 3.3 | |
Return on capital | % | 13.3 | 10.0 | 11.1 | 10.5 | 7.4 | |
Exports to sales | % | 0 | 0 | 0.1 | 0.2 | 0.6 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 1 | 3 | 9 | 24 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 1 | 3 | 9 | 24 | |
Fx outflow | Rs m | 0 | 8 | 18 | 301 | 217 | |
Net fx | Rs m | 0 | -7 | -15 | -292 | -193 |
AAREY DRUGS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 7 | 29 | 55 | 5 | -13 | |
From Investments | Rs m | -12 | -9 | -29 | -32 | 4 | |
From Financial Activity | Rs m | -25 | -18 | -25 | 23 | 14 | |
Net Cashflow | Rs m | -30 | 1 | 1 | -5 | 5 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Mihir R Ghatalia | COMP SEC: Preeti Paresh Rathi | YEAR OF INC: 1990 | BSE CODE: 524412 | FV (Rs): 10 | DIV YIELD (%): - |
Read: AAREY DRUGS 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: ADANI PORTS & SEZ ADANI ENTERPRISES ZOMATO APOLLO HOSPITALS ADANI TOTAL GAS
Compare AAREY DRUGS With: ADANI PORTS & SEZ ADANI ENTERPRISES ZOMATO APOLLO HOSPITALS ADANI TOTAL GAS
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.